A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

by Vieta, E., Montgomery, S., Sulaiman, A.H., Cordoba, R., Huberlant, B., Martinez, L., Schreiner, A.
Published 2012